Pyridine-containing compound catabolic process

pathway activity — cross-omics
GO:0072526Cross-omicsPROTEIN-MS → RNACellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Pyridine-containing compound catabolic process pathway is significantly associated with the RNA expression of multiple genes, with the STOMACH cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are LAMC2, TRIM24, and SRGN, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Pyridine-containing compound catabolic process activity versus LAMC2 in STOMACH (Pearson r = -0.68).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
STOMACHLAMC2 →-3.942-0.226.002.00235
BLOOD_LeukemiaTRIM24 →-0.702-0.152<.001.00535
LUNG_NSCLC_LUADSRGN →+5.889+0.223<.001<.00135
SKINLONRF3 →+1.572+0.287<.001<.00135
LUNG_NSCLC_LUADMFF →+0.793+0.166<.001<.00135
BREASTGALK2 →+0.662+0.161.002.00935
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0072526 vs LAMC2 — STOMACH

Per-sample scatter of Pyridine-containing compound catabolic process activity vs LAMC2 in STOMACH.

Explore this scatter interactively →

Exploration